Corcept Therapeutics
CORT
$22.48
Share price
-2.26%
Change (1 day)
-0.09%
Change (1 year)
Categories
Earnings for Corcept Therapeutics (CORT)
Earnings in 2023 (TTM): $0.10 B
According to Corcept Therapeutics 's latest financial reports the company's current earnings (TTM) are $0.10 B. a decrease over its 2022 earnings that were of $0.11 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Corcept Therapeutics from 2003 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | $0.10 B | -4.75% |
| 2022 | $0.11 B | -9.51% |
| 2021 | $0.12 B | -2.91% |
| 2020 | $0.12 B | 14.87% |
| 2019 | $0.11 B | 24.71% |
| 2018 | $89.49 M | 69.32% |
| 2017 | $52.85 M | 419.26% |
| 2016 | $10.17 M | -395.64% |
| 2015 | -$3.45 M | -87.53% |
| 2014 | -$27.62 M | -33.44% |
| 2013 | -$41.5 M | |
| 2011 | -$32.34 M | 17.84% |
| 2010 | -$27.44 M | 35.5% |
| 2009 | -$20.25 M | 2.84% |
| 2008 | -$19.69 M | 60.81% |
| 2007 | -$12.25 M | -52.14% |
| 2006 | -$25.59 M | 20.91% |
| 2005 | -$21.16 M | 31.87% |
| 2004 | -$16.05 M | 60.54% |
| 2003 | -$10 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 15,719.99% | 🇺🇸 USA |
 Novartis NVS | $9.43 B | 8,697.38% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | 2,945.25% | 🇺🇸 USA |
 Eli Lilly LLY | $6.55 B | 6,009.69% | 🇺🇸 USA |
 Merck MRK | $3.03 B | 2,728.99% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.44 B | 7,767.12% | 🇺🇸 USA |
 MannKind Corp MNKD | -$10.38 M | -109.67% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -$0.16 B | -240.07% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.18 B | 75.76% | 🇺🇸 USA |